Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
about
Natural killer cells in hepatitis C: Current progressEmerging concepts in immunity to hepatitis C virus infection.Phenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus InfectionHepatitis C and Innate Immunity: Recent AdvancesAdoptive immunotherapy with liver allograft–derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized miceEffect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus InfectionRegulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DCRegulation of NK cell repertoire and function in the liver.Intrahepatic IL-10 maintains NKG2A+Ly49- liver NK cells in a functionally hyporesponsive state.Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.Natural killer cell function and dysfunction in hepatitis C virus infection.Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.Human liver transplantation as a model to study hepatitis C virus pathogenesisInnate immune cell networking in hepatitis C virus infectionThe effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis CAssessment of immunological changes in Epstein-Barr virus co-infection in Egyptian chronic HCV patients.Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.NK cells, innate immunity and hepatitis C infection after liver transplantation.Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.Coinfection with HIV-1 and HCV--a one-two punch.Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis CA novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.Glances in Immunology of HIV and HCV InfectionHepatitis viruses: live and let die.Natural killer cells: multifaceted players with key roles in hepatitis C immunity.Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.Recurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.Hepatitis C virus impairs natural killer cell-mediated augmentation of complement synthesis.MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.Immune modulation by the hepatitis C virus core protein.The effects of hepatitis C virus core protein on functional responses in the NK cell line YTS.Activation of natural killer cells by hepatitis C virus particles in vitro.A synergistic interferon-gamma production is induced by mouse hepatitis virus in interleukin-12 (IL-12)/IL-18-activated natural killer cells and modulated by carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a receptor.Partial Activation of natural killer and γδ T cells by classical swine fever viruses is associated with type I interferon elicited from plasmacytoid dendritic cells.Immunopathogenesis of hepatitis C virus infection and hepatic fibrosis: New insights into antifibrotic therapy in chronic hepatitis C.Compromised function of natural killer cells in acute and chronic viral hepatitis.Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
P2860
Q26773264-7F4C3652-A027-4819-B233-3A6DE36605BFQ27002588-800C684C-A55B-4834-8176-09941CF5D9EDQ27481031-D6B3B1BB-F62A-448B-A8F9-4CE17633F019Q27487394-D2FF3DE8-F2B3-413A-BA7B-1CEECCF9C1B2Q27490263-D3CAD765-DC90-4DC0-BCE5-E81B5988D043Q27490541-A5C51377-5B11-4C43-9C93-B201959BFE5FQ30414152-80820881-721F-4A24-9B6B-0C42C6B5C5CCQ30430960-80E81CD1-1201-4605-8605-4C5851E76FE7Q30435854-E8F5EC93-4780-4AC3-8FCA-B854E9F084C6Q33750016-772B190F-1D4C-47AE-B5C3-CE59933EFB59Q33892695-4E6CB420-E10A-412D-A100-EE445C6D0E38Q34073021-F551DE7A-A2EB-437A-B8EB-5ADE884744D8Q34197528-3D64904A-C412-4C2C-9FFF-4A6D213E1D04Q34341382-8E2D1CC0-50A9-4730-869F-352E8FDBC21EQ34398332-D110A343-BA58-48CD-9459-7393788ED6D8Q34548411-912514E8-9017-47DE-8381-B8651084E0DAQ34804539-0B9165EB-C882-49E9-A331-F77F3CB5950BQ35019869-1C106466-5DE8-48A8-A8E8-FC41E8BE5113Q35094287-AEEE6C78-6FD7-42A3-BA81-7FC0A3AE2159Q35137038-0E76DD16-B8B9-473A-A3CD-BEAB2B5783F4Q35508148-100B2572-E635-4CFA-A37C-0EBDFE0BA570Q35579175-6E13E71A-09E9-4A09-973C-E26E677AD6F3Q36032051-37C7E274-A723-4762-B2A2-3AA56EFD78FFQ36758656-24709B3B-40E4-4BC3-9791-0D9396B1D8C1Q37151472-5C4D0996-08F8-4169-9C06-B60D326AA52CQ37224653-64BEA3D9-CFC0-424F-9922-75670EDF67A1Q37252732-EF8C19D9-633F-484D-83C9-A42017532840Q37326768-917BC589-7621-4F41-9AEB-9F57A6A873BFQ37346066-ED6BEF54-16A0-44A2-B794-383237EF8452Q38081919-E3FC820B-6DA6-4BB3-9E11-C182E4893265Q38329712-5B1DDF0B-2162-4C35-B7F0-6717F3A14888Q38899741-D1F7E028-25DB-4D5E-A83F-8BB04A6B2A98Q39090584-DF44D503-66CD-4466-B8B9-E2183D7B3CA2Q39474013-A21826B2-D65B-4838-8901-518B07658114Q39522746-81C8D560-F6DE-4046-9C25-1C8DC5380D83Q39796186-26169D33-7519-4738-852E-2238925EF09EQ40198368-2F613E99-4CAD-4AB4-BC7F-958AC165980DQ40211269-42A32BDC-056D-42A8-AE93-EC89C017B216Q42260265-CD1A4BD5-4177-462B-80CD-6319BDBE631AQ42983326-183EF38D-A8FF-4EA5-8451-F08F8BA24784
P2860
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
@ast
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
@en
type
label
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
@ast
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
@en
prefLabel
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
@ast
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
@en
P2860
P356
P1476
Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
@en
P2093
Hugo R Rosen
Lucy Golden-Mason
P2860
P304
P356
10.1002/LT.20708
P577
2006-03-01T00:00:00Z